Acrivon Therapeutics, Inc.
ACRV • NASDAQ • Stock Fundamentals
Acrivon Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Peter Blume-Jensen, with a market cap of $71.5M.
Market Cap$71.5M
Employees61.0
CEOPeter Blume-Jensen
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
ACR
Acrivon Therapeutics, Inc. FAQ
Common questions about Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. (ACRV) has a market capitalization of $71.5M and trades on NASDAQ.
Acrivon Therapeutics, Inc. has approximately 61 employees.